Oral Session 2-9B Multiple Myeloma: Basic (2)

[OS2-9B-2] Detection of IGH translocations in multiple myeloma using next generation sequencing

Takashi Kanamori^1,2, Masashi Sanada², Masaki Ri¹, Hiroo Ueno³, Dai Nishijima², Takahiko Yasuda², Sho Aoki¹, Arisa Asano¹, Takuto Tachita¹, Shiori Kinoshita¹, Tomoko Narita¹, Asahi Ito¹, Shigeru Kusumoto¹, Atsushi Inagaki⁴, Yuta Masuda⁵, Nobuhiko Kobayashi⁶, Yusuke Shiozawa^3,7, Kenichi Yoshida³, Masahiro Nakagawa³, Yasuhito Nanya³, Yuichi Shiraishi⁸, Kenichi Chiba⁹, Hiroko Tanaka⁹, Hirokazu Komatsu¹, Satoru Miyano⁹, Hiroshi Handa⁵, Seishi Ogawa^3,10,11, Shinsuke Iida¹ (1.Department of Hematology and Oncology, Nagoya City University, Nagoya, Japan, 2.Clinical Research Center, Nagoya Medical Center, Nagoya, Japan, 3.Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan, 4.Hematology and Oncology, Nagoya City West Medical Center, Nagoya, Japan, 5.Graduate School of Health Sciences, Gunma University, Maebashi, Japan, 6.Department of Medicine and Clinical Science, Gunma University, Maebashi, Japan, 7.Department of. Pediatrics, University of Tokyo, Tokyo, Japan, 8.Division of Cellular Signaling, National Cancer Center Research Institute, Japan, 9.Human Genome Center, Insti. of Med. Science, University of Tokyo, Tokyo, Japan, 10.WPI-ASHBi, Kyoto University, Kyoto, Japan, 11.Center for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden)